NCT02489058View on ClinicalTrials.gov

A Study of Long-Term Responders on Olaparib

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 16, 2021

Study Completion Date

August 31, 2022

Conditions
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Trial Locations (8)

2031

South Eastern Sydney Local Health District, Randwick

V5Z 4E6

British Columbia Cancer Centre, Vancouver

Unknown

Ottawa Hospital Research Institute, Ottawa

Institute of European Oncology, Milan

Vall d'Hebron, Barcelona

Edinburgh Cancer Research Centre, Edinburgh

M5G 2M9

Princess Margaret Cancer Centre, Toronto

SM2 5PT

The Royal Marsden, Sutton

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02489058 - A Study of Long-Term Responders on Olaparib | Biotech Hunter | Biotech Hunter